Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluating the Effectiveness and Feasibility of Community Based SARS-CoV-2 Antigen Rapid Diagnostic Testing (Ag-RDT) in the Myanmar Migrant Community, Tak Province Along the Thai Myanmar Border for Controlling Coronavirus Transmission

NCT05557513 is registered in ClinicalTrials.gov with University of Oxford as lead sponsor.

NCT NCT05557513
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05557513 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluating the Effectiveness and Feasibility of Community Based SARS-CoV-2 Antigen Rapid Diagnostic Testing (Ag-RDT) in the Myanmar Migrant Community, Tak Province Along the Thai Myanmar Border for Controlling Coronavirus Transmission
Lead sponsor
University of Oxford
Phase
Not applicable
Overall status
Completed
Start date
August 18, 2022
Completion date
December 31, 2022
Enrollment
1,310 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19 pandemic